Products
Online Inquiry
Ilaprazole sodium
Cat. No.:
0225LY-1341
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Ilaprazole sodium is a benzimidazole prodrug and irreversible proton pump inhibitor that prevents gastric acid production by binding to the H+/K+ ATPase in the secretory canaliculi of parietal cells.
Synonym:
IY-81149 sodium; 172152-50-0; Sodium ilaprazole; Ilaprazole (sodium); Sodium;2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-5-pyrrol-1-ylbenzimidazol-3-ide; Sodiumilaprazole; 1H-Benzimidazole, 2-(((4-methoxy-3-methyl-2-pyridinyl)methyl)sulfinyl)-5-(1H-pyrrol-1-yl)-, sodium salt; 1H-Benzimidazole, 2-(((4-methoxy-3-methyl-2-pyridinyl)methyl)sulfinyl)-6-(1H-pyrrol-1-yl)-, sodium salt (1:1); 1H-Benzimidazole, 2-[[(4-methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-5-(1H-pyrrol-1-yl)-, sodium salt; 1H-Benzimidazole, 2-[[(4-methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-6-(1H-pyrrol-1-yl)-, sodium salt (1:1)
CAS No.:
172152-50-0
Compound CID:
121595900
Formula:
C19H17N4NaO2S
Formula Weight:
388.42
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ilaprazole sodium can be used in gastroenterology to investigate the long-term suppression of gastric acid through proton pump inhibition.
Library Information
Target:
TOPK; Proton pump
Receptor:
TOPK; Proton pump
Pathways:
MAPK; Membrane transporter/Ion channel
Plate Number:
AOCL-18
Plate Location:
b8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
71 mg/mL; 182.79 mM
Water Max Solubility:
50 mg/mL; 128.73 mM
